TTOO - Why In Vitro Diagnostics Company T2 Biosystems Shares Gaining Today | Benzinga
T2 Biosystems, Inc. (NASDAQ: TTOO) shares are trading higher on Wednesday after the company submitted a 510(k) premarket notification to the U.S. Food and Drug Administration to expand the use of its FDA-cleared T2Candida Panel to include pediatric testing.
The T2Candida Panel is the only FDA-cleared diagnostic test able to detect sepsis-causing Candida pathogens directly from blood, in just 3-5 hours, without the need ...